NCT06405113View on ClinicalTrials.gov

FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2027

Conditions
Gastric Cancer
Interventions
COMBINATION_PRODUCT

Fecal Microbiota Transplantation (FMT)+chemotherapy+immunotherapy

Participants received Fecal Microbiota Transplantation (FMT) combined with (Oxaliplatin + S-1)+Sintilimab

Trial Locations (1)

Unknown

RECRUITING

Changzhou No.2 People's Hospital, Changzhou

All Listed Sponsors
lead

Changzhou No.2 People's Hospital

OTHER